Purpose This clinical study was performed to establish the incidence of symptomatic deep vein thrombosis and pulmonary embolism after shoulder surgery as the incidence of venous thrombo-embolism complicating shoulder surgery is poorly described in literature. Methods We reviewed retrospectively clinical records of 920 consecutive patients who had any surgical procedure performed on their shoulder in Glan Clwyd Hospital, North Wales and a further 1,421 consecutive patients who had surgery in Morriston and Singleton Hospitals, South Wales. Patients' records were assessed for any admissions due to proven VTE; we investigated for any radiological results suggestive of venous thrombo-embolism and for deaths in the post-operative period. Results We analyzed data of 2,341 patients. There was one fatal PE in this group, whereby the patient died within 48 hours following reverse shoulder replacement, and post mortem revealed massive pulmonary embolism. There were a further three cases of symptomatic, non-fatal PE. There were six cases of symptomatic DVT of lower limb. All these cases were treated successfully with anticoagulation. No upper limb DVT was identified. Conclusion Recent studies suggest that DVT prevalence following shoulder arthroplasty is as high as 13 %. In our study we examined occurrence of symptomatic VTE only. According to our results the prevalence of symptomatic DVT following shoulder surgery is 0.26 %, symptomatic PE 0.17 % and combined prevalence of VTE is 0.43 %. We would advise careful thought about the risk of thrombosis and use mechanical prophylaxis in shoulder surgery, especially for longer procedures. We would not recommend routine pharmacological prophylaxis unless there are additional risk factors.
Introduction
Venous thrombo-embolism (VTE) is a well-recognized complication of hip and knee arthroplasty, and its prevalence is well described in current literature. In contrast, the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) following shoulder surgery has not been wellcharacterized in the literature.
There are very few reports of VTE prevalence after shoulder arthroplasty and case reports of thrombo-embolic events after shoulder arthroscopy only. However, the data on incidence of symptomatic DVT and PE following any shoulder surgery is very poor. The purpose of the present study was to determine the incidence of symptomatic deep vein thrombosis and pulmonary embolism following shoulder surgery.
Materials and methods
We reviewed retrospectively clinical records of 920 consecutive patients who had any surgical procedure performed on their shoulder in Glan Clwyd Hospital, Rhyl, North Wales, UK and a further 1,421 consecutive patients who had surgery in Morriston and Singleton Hospitals, Swansea, South Wales, UK. Patients were identified using operating theatre database in both hospitals. Any procedure that involved shoulder joint or proximal humerus was included. Patients' records were assessed for any hospital admissions due to proven VTE according to ICD-10 and clinical coding databases. Furthermore, radiological investigations of all the patients were assessed for results suggestive of venous thromboembolism. This was performed by searching the PACS (Picture Archiving and Communications System) database of each of the patients for any USS Doppler study, ventilation-perfusion (VQ) scan or computed tomography (CT) scan of the chest / chest tomography pulmonary angiogram (CTPA) and the results of the investigation were noted. The peri-operative deaths were examined for any evidence of thrombo-embolic disease. Full clinical notes of each patient with positive radiological test or coded diagnosis of VTE were examined. Only VTE cases diagnosed within six weeks of operation were considered to be related to surgery.
Results
Records of 2,341 patients who had any surgical procedure on their shoulder were analyzed. Those included 352 who had shoulder arthroplasty, and 1,281 who had a shoulder arthroscopic procedure (Fig. 1) .
There was one fatal PE in this group; a 73-year-old female patient died within 48 hours following shoulder replacement, post mortem revealed massive pulmonary embolism. She had BMI of 34 but no medical co-morbidities. This case was described by Madhusudhan et al. [1] . There were a further three cases of symptomatic, non-fatal PE at one, four and six weeks after surgery. There were six cases of symptomatic DVT of lower limb (four distal and two proximal). All these cases were treated successfully with anticoagulation. No upper limb DVT was identified. There were 23 patients who had negative tests for suspected thrombosis within six weeks from time of shoulder surgery. Eleven patients were diagnosed to have DVT or PE during their lifetime, but not within six weeks from shoulder surgery. According to our results the incidence of symptomatic DVT following shoulder surgery is 0.26 %, symptomatic PE 0.17 % and combined incidence of VTE is 0.43 % ( Table 1) .
Discussion
The goal of this study was to identify the frequency of thromboembolic events following shoulder surgery, because little previous literature exists on this topic.
In our study we examined occurrence of symptomatic VTE only. The results of our study show incidence of VTE in shoulder arthroplasty is at similar level as Lyman et al. [2] shown in their study, when they assessed symptomatic VTE following shoulder arthroplasty. They report the DVT incidence of 0.5 % and PE incidence of 0.23 %. Sperling and Cofield [3] described in their paper the prevalence of symptomatic PE following shoulder arthroplasty to be 0.17 %. Saleh et al. [4] quote the incidence of VTE after shoulder arthroplasty in their systematic review to be at a rate from 2 % to 16 %. Navarro et al. [5] reported a VTE rate of 1 % in the cohort of 2,574 patient who had shoulder arthroplasty. Table 2 represents the reported incidence of VTE by other authors with methodology used.
Nordstrom et al. [8] established the incidence of deep-vein thrombosis within the urban population to be at a level of 0.05 %. Incidence of DVT following shoulder surgery appears to be increased five-fold. Still, it is a much lower than reported incidence of thrombosis following hip or knee arthroplasty.
The prevalence of asymptomatic VTE after shoulder surgery is probably much higher. Willis et al. [9] reported 13 % prevalence of asymptomatic VTE following shoulder arthroplasty. The importance of asymptomatic thrombosis remains debatable and of unknown significance.
Authors acknowledge several limitations of the study
There are limitations to using administrative databases for research. The clinical coding of diagnosis and readmission according to ICD-10 was very poor. Only one patient who suffered postoperative symptomatic VTE had disease coded correctly and was identified using clinical coding. This patient and all other patients were found to have positive radiological investigations for VTE when authors searched the PACS database. Authors advocate that any research based on coding of diagnoses alone need to be made with care as there may be some underreporting of the incidence of VTE. In recent large systematic review of literature, Dattani et al. [10] report an incidence of VTE after shoulder arthroscopy at a level of 0.038 % and after shoulder arthroplasty at a level of 0.52 %. The authors admitted though that the literature they reviewed was not always of good quality, with lack of technique used to diagnose VTE and no localization of DVT in many papers. The vast majority of the cases they reviewed comes from a paper by Jameson et al. [6] (65,302 of 92,440 arthroscopic procedures and 10,229 of 37,217 arthroplasty procedures), and their paper is based only on clinical coding in NHS. Because of that fact, we are of the opinion that reported incidence may be under estimated.
Another limitation of our study is the possibility that some patients moved from the catchment areas of the hospitals that were investigated and were diagnosed with VTE in other institutions. The authors believe this could be related to only a small number of patients who had surgery due to trauma and who returned home after discharge from hospital. Both hospitals where the research was conducted are located in rural parts of Wales, and in the opinion of the authors it is not likely patients would be assessed and investigated in neighbouring hospitals due to large distance they need to travel. Still, the quoted incidence of VTE following shoulder surgery could be under estimated and real incidence theoretically may be higher. This is one of the largest studies that the authors are aware of that assesses the incidence of VTE following any surgery on shoulder joint. The cross-referencing and use of PACS and radiological data in conjunction with clinical coding is a strength of the study. Furthermore, the fact that it was conducted in two separate institutions in South and North Wales, with a large number of consultants involved, should make the final result more valid. The incidence of VTE was similar in both studied institutions.
Amongst patients who were diagnosed with DTV or PE following shoulder surgery, there were no significant risk factors when comparing to the rest of the population studied. The incidence of obesity and ASA grade was similar. None of patients who developed VTE had previous history of thrombo-embolic disease. Therefore the authors believe it is difficult to predict and to do risk assessment scoring when considering patients for additional prophylaxis. Patients undergoing shoulder arthroplasty have higher risk of VTE than the rest of those undergoing other procedures on their shoulder.
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